A BRIEF HISTORY

roland_mehl

ROLAND MEHL , FOUNDER

The Prix Galien was created in France by pharmacist Roland Mehl, whose aim was to promote the country’s significant advances in pharmaceutical research.

Until the establishment of the Prix Galien, this discipline remained unrecognized. Mehl brought together an eminent jury consisting of clinicians, toxicologists, pharmacologists and pharmacists to select and honor the most important drugs introduced to the public market and the most significant research teams in the pharmaceutical field.

Since then, The Prix Galien has been introduced across Europe and Canada and is now the most prestigious award of its kind in 11 countries. In addition, an International Prix Galien award is given each year, selected from previous winners.

The Prix Galien recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines, and is now considered the industry’s equivalent of the Nobel Prize, the highest accolade for pharmaceutical research and development.

The Prix Galien was inaugurated in the United States in September 2007 under the auspices of an exceptional awards committee that includes 7 Nobel Laureates.


SEE ALSO